Jesper Bøje Andersen
Professor
Andersen Group
Ole Maaløes Vej 5
2200 København N.
4th Symposium on Translational Genomics with a Special Focus on Liver
Andersen, Jesper Bøje (Invited speaker)
Mar 2016Activity: Talk or presentation types › Lecture and oral contribution
AASLD: Genomics-Based Directions for Targeted Therapies in Cholangiocarcinoma.: Experimental Hepatocarcinogenesis
Andersen, Jesper Bøje (Speaker)
2013Activity: Talk or presentation types › Lecture and oral contribution
Aging (Journal)
Andersen, Jesper Bøje (Editor)
2009 → 2013Activity: Peer-review and editorial work types › Editor of Research journal › Research
American Association for Cancer Research (AACR) (External organisation)
Andersen, Jesper Bøje (Member)
2009Activity: Membership types › Membership in research network
BRIC-Lund University Retreat
Andersen, Jesper Bøje (Speaker)
2015Activity: Talk or presentation types › Lecture and oral contribution
Bench to Bedside: New Directions for Therapy in Primary Liver Cancer: Cancer Biology Symposium
Andersen, Jesper Bøje (Invited speaker)
2013Activity: Talk or presentation types › Lecture and oral contribution
Bench to Bedside: Translational genomics identifies promising targeted therapy for cholangiocarcinoma: Humanitas Fondazione per la Ricerca Seminars
Andersen, Jesper Bøje (Lecturer)
2013Activity: Talk or presentation types › Lecture and oral contribution
BioPeople: Future of Oncology Biomarkers Seminar & Biomed
Andersen, Jesper Bøje (Panel member)
May 2017Activity: Talk or presentation types › Lecture and oral contribution
Breast Cancer Research; Biochemical Pharmacology (Journal)
Andersen, Jesper Bøje (Review editor)
2008Activity: Peer-review and editorial work types › Peer review of manuscripts › Research
British Journal of Cancer; Journal of Cancer Therapeutics & Research, BMC Cancer; Cancer Research; Clinical Cancer Research; PLoS ONE (Journal)
Andersen, Jesper Bøje (Review editor)
2012Activity: Peer-review and editorial work types › Peer review of manuscripts › Research
Center for Excellence and Integrative Cancer Biology and Genomics, NIH
Andersen, Jesper Bøje (Invited speaker)
17 Mar 2016 → 18 Mar 2016Activity: Talk or presentation types › Lecture and oral contribution
Chair: Liver cancer session
Andersen, Jesper Bøje (Panel member)
Sep 2017Activity: Talk or presentation types › Lecture and oral contribution
Cholangiocarcinoma Foundation Congress: Translational genomics: Application of murine models for understanding tumor heterogeneity
Andersen, Jesper Bøje (Invited speaker)
3 Feb 2016 → 6 Feb 2016Activity: Talk or presentation types › Lecture and oral contribution
EASL: Modulation of Demethylation and Antitumor Potential of Zebularine in Liver Cancer
Andersen, Jesper Bøje (Speaker)
2009Activity: Talk or presentation types › Lecture and oral contribution
EU-Life: Epigenetics and Disease
Andersen, Jesper Bøje (Organizer)
11 May 2015 → 13 May 2015Activity: Participating in an event - types › Organisation of and participation in conference
Emerging Targets in the treatment of Cholangiocarcinoma: Liver cancer seminar
Andersen, Jesper Bøje (Lecturer)
20 Nov 2013Activity: Talk or presentation types › Lecture and oral contribution
Eu-Life: Translational Working Group (External organisation)
Andersen, Jesper Bøje (Member)
2014Activity: Membership types › Membership in committee, council, board
European Network Study for Cholangiocarcinoma: 1st International monothematic congress in cholangiocarcinoma: Molecular pathogenesis of intrahepatic cholangiocarcinoma
Andersen, Jesper Bøje (Invited speaker)
4 May 2016 → 6 May 2016Activity: Talk or presentation types › Lecture and oral contribution
European Network Study for Cholangiocarcinoma: ENS-CCA (External organisation)
Andersen, Jesper Bøje (Board member)
Apr 2015Activity: Membership types › Membership in research network
Gastroenterology; Liver Transplantation; Clinical Gastroenterology & Hepatology (Journal)
Andersen, Jesper Bøje (Review editor)
2011Activity: Peer-review and editorial work types › Peer review of manuscripts › Research
Genomic and Genetic Characterization of Human Cholangiocarcinoma Identify Therapeutic Opportunities for Tyrosine Kinase Inhibitors
Andersen, Jesper Bøje (Speaker)
2011Activity: Talk or presentation types › Lecture and oral contribution
Georgetown University, Lombardi Comprehensive Cancer Center: Emerging Genomics-based Targets in the treatment of Cholangiocarcinoma: Ruesch symposium on HCC
Andersen, Jesper Bøje (Invited speaker)
2013Activity: Talk or presentation types › Lecture and oral contribution
Gut, Molecular Carcinogenesis, Oncogene (Journal)
Andersen, Jesper Bøje (Review editor)
2013Activity: Peer-review and editorial work types › Peer review of manuscripts › Research
Hallas-Møller Fellowship
Andersen, Jesper Bøje (Other)
Apr 2015Activity: Talk or presentation types › Lecture and oral contribution
Hepatobiliary cancers: Translational Genomics Directs Therapeutic Options
Andersen, Jesper Bøje (Invited speaker)
Aug 2015Activity: Talk or presentation types › Lecture and oral contribution
Hepatology (Journal)
Andersen, Jesper Bøje (Review editor)
2009Activity: Peer-review and editorial work types › Peer review of manuscripts › Research
Hepatology (Journal)
Andersen, Jesper Bøje (Member of Editorial Board)
1 Feb 2017 → …Activity: Peer-review and editorial work types › Editor of Research journal › Research
Highlight from Hepatology 2015: From Chronic Hepatitis to HCC: Molecular pathogenesis and current therapy in intrahepatic cholangiocarcinoma
Andersen, Jesper Bøje (Invited speaker)
Oct 2015Activity: Talk or presentation types › Lecture and oral contribution
ILCA workshop: Signalling pathways and molecular therapies in liver cancer: Rationale for Targeted Therapies in Intrahepatic Cholangiocarcinoma
Andersen, Jesper Bøje (Speaker)
2012Activity: Talk or presentation types › Lecture and oral contribution
ILCA: Application of Translational Genomics for Targeted Therapy in Cholangiocarcinoma
Andersen, Jesper Bøje (Speaker)
2012Activity: Talk or presentation types › Lecture and oral contribution
ILCA: Decoding Tumor Heterogeneity Informs Targeted Therapies in Intrahepatic Cholangiocarcinoma
Andersen, Jesper Bøje (Speaker)
4 Sep 2014Activity: Talk or presentation types › Lecture and oral contribution
ILCA: Genomic and Epigenetic-Based Prediction of Response to Zebularine Therapy in Human Liver Cancer
Andersen, Jesper Bøje (Speaker)
2009Activity: Talk or presentation types › Lecture and oral contribution
ILCA: Genomic and Genetic Characterization of Human Cholangiocarcinoma Identify Therapeutic Opportunities for Tyrosine Kinase Inhibitors
Andersen, Jesper Bøje (Speaker)
2011Activity: Talk or presentation types › Lecture and oral contribution
ILCA: Genomics-Based Directions for Targeted Therapies in Cholangiocarcinoma
Andersen, Jesper Bøje (Speaker)
2013Activity: Talk or presentation types › Lecture and oral contribution
ILCA: Molecular classification and key drivers of intrahepatic CCA
Andersen, Jesper Bøje (Invited speaker)
Sep 2017Activity: Talk or presentation types › Lecture and oral contribution
ILCA: Transcriptomic classification and survival prediction of human cholangiocarcinoma
Andersen, Jesper Bøje (Speaker)
2010Activity: Talk or presentation types › Lecture and oral contribution
ISICR: The Ribosomal Machinery is a Primary Target of RNase-L Regulation and may mediate its Roles in Senescence and Longevity
Andersen, Jesper Bøje (Speaker)
2007Activity: Talk or presentation types › Lecture and oral contribution
International Journal of Rare Diseases & Orphan Drugs (Journal)
Andersen, Jesper Bøje (Member of Editorial Board)
2016 → …Activity: Peer-review and editorial work types › Editor of Research journal › Research
International Liver Cancer Association (ILCA) (External organisation)
Andersen, Jesper Bøje (Member)
2010Activity: Membership types › Membership in research network
Journal of National Cancer Institute (Journal)
Andersen, Jesper Bøje (Review editor)
2007Activity: Peer-review and editorial work types › Peer review of manuscripts › Research
Korean liver week
Andersen, Jesper Bøje (Invited speaker)
Jun 2017Activity: Talk or presentation types › Lecture and oral contribution
Liver Cancer Seminar Series
Andersen, Jesper Bøje (Invited speaker)
1 Dec 2016Activity: Talk or presentation types › Lecture and oral contribution
Molecular Classification of Cholangiocarcinoma and Therapeutic Implications
Andersen, Jesper Bøje (Invited speaker)
9 May 2014Activity: Talk or presentation types › Lecture and oral contribution
Molecular pathogenesis of cholangiocarcinoma
Andersen, Jesper Bøje (Lecturer)
Oct 2015Activity: Talk or presentation types › Lecture and oral contribution
Mutagen-Brazil: Translational Research
Andersen, Jesper Bøje (Invited speaker)
28 Jan 2016 → 30 Jan 2016Activity: Talk or presentation types › Lecture and oral contribution
NAFLD
Andersen, Jesper Bøje (Invited speaker)
24 Nov 2017Activity: Talk or presentation types › Lecture and oral contribution
Nature Genetics (Journal)
Andersen, Jesper Bøje (Review editor)
2015Activity: Peer-review and editorial work types › Peer review of manuscripts › Research
Novel Therapeutic Approaches for Treatment of Primary Liver Cancer: Epigenomic-driven therapy
Andersen, Jesper Bøje (Speaker)
2012Activity: Talk or presentation types › Lecture and oral contribution
Nucleic Acids Research (Journal)
Andersen, Jesper Bøje (Review editor)
2006Activity: Peer-review and editorial work types › Peer review of manuscripts › Research
Riccardo Cortese memorial lecture
Andersen, Jesper Bøje (Invited speaker)
Jul 2017Activity: Talk or presentation types › Lecture and oral contribution
ID: 93714085
Most downloads
-
717
downloads
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles - correction
Research output: Contribution to journal › Comment/debate › Research › peer-review
Published -
574
downloads
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
198
downloads
MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma
Research output: Contribution to journal › Journal article › Research › peer-review
Published